European Pharmaceutical Review

NOVEMBER 14, 2023

In the document, it was reasoned that global shortage of these vials threatened the delivery of COVID-19 vaccines and availability of existing parenteral products. Europe’s pharmaceutical packaging market to value over $35bn by 2028 The post USP General Chapter <660>—Glass revised appeared first on European Pharmaceutical Review.

Packaging 105

Packaging Vaccines Documentation FDA 105

Pharmaceutical Technology

SEPTEMBER 15, 2022

According to GlobalData’s report, Paxlovid, the company’s small-molecule Covid-19 oral therapy, was shown to reduce Covid-19 infections by 32% in adults and is forecast to be the top-selling drug by total sales, generating $81bn between 2021 and 2028. Bristol Myers Squibb (BMS) documented a 9.1% AbbVie reported a 22.7%

Vaccines 108

Vaccines Documentation Compounding FDA 108

Pharmaceutical Technology

MARCH 30, 2023

billion in 2028. Earlier in March, the FDA shared a draft guidance on how to run clinical trials for the accelerated approval of cancer drugs. Earlier in March, the FDA shared a draft guidance on how to run clinical trials for the accelerated approval of cancer drugs.

Chemotherapy 52

Chemotherapy Packaging FDA Documentation 52

pharmaphorum

SEPTEMBER 13, 2022

The first well-documented case of multiple myeloma was reported in 1844 by renowned British surgeon Samuel Solly. 2001– FDA green lights revolutionary treatments. Just over a decade after it was developed by biochemist Nicholas Lyndon, Imatinib received US Food and Drug Administration (FDA) approval in 2001.

Chemotherapy 98

Chemotherapy Immunization FDA Documentation 98

The Checkup by Singlecare

DECEMBER 12, 2024

manufactures, was approved by the Food and Drug Administration ( FDA ) in August 2015 for hypoactive sexual desire disorder ( HSDD ) in pre-menopausal women. Addyi is currently only available as a brand-name drug , but a generic Addyi may be available after 2028. What is the generic for Addyi ? Is Addyi covered by insurance?

Insurance 52

Insurance Insurance Coverage Documentation FDA 52

The FDA Law Blog

JANUARY 2, 2025

By Ritte van Laack As we previously reported in 2022, FDA published a proposed rule defining the nutrient content claim healthy. FDA received more than 400 comments, resulting in a final rule published on December 27, 2024, covering more than 100 pages. The final rule maintains the concept of the proposed rule.

FDA 52

FDA Labelling Documentation 52